Entering text into the input field will update the search result below

Biomarin Pharmaceutical (NASDAQ:BMRN): Q2 EPS of -$0.16 beats by $0.14. Revenue of $136.8M...

Jul. 25, 2013 4:22 PM ETBioMarin Pharmaceutical Inc. (BMRN) StockBMRNBy: Gaurav Batavia, SA News Editor
Biomarin Pharmaceutical (NASDAQ:BMRN): Q2 EPS of -$0.16 beats by $0.14. Revenue of $136.8M (+10.3% Y/Y) beats by $2.47M. Shares -1% AH. (PR)

Recommended For You

More Trending News

About BMRN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BMRN--
BioMarin Pharmaceutical Inc.